Delivery Order SPE2DB25D3020-SPE2DB25FWHPZ
Award Date 5/20/25
Potential Completion Date 5/21/25
Potential Value $8.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $46,657.70 to AmerisourceBergen Drug Corp for the supply of Vaxneuvance 0.5 ML syringes on September 15, 2025, with completion scheduled for September 16, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a $6,512.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Vaxneuvance 0.5 mL syringes on August 4, 2025, with an ultimate completion date of August 5, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.999 billion and extending through December 2026. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,301.55 to AmerisourceBergen Drug Corp on May 8, 2025, for the supply of Vaxneuvance 0.5 ML syringes. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The...
- The Defense Logistics Agency awarded a delivery order valued at $6,715.65 to AmerisourceBergen Drug Corp for 0.5 mL Vaxneuvance syringes, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price delivery order was issued with no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, is fulfilling this...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,000.54 to AmerisourceBergen Drug Corp for the supply of Vaxneuvance 0.5 ML syringes on August 26, 2025, with an ultimate completion date of August 27, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Vaxneuvance is a pneumococcal vaccine product, reflecting the critical role AmerisourceBergen...
- The Defense Logistics Agency awarded a $13,703.90 delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Vaxneuvance 0.5 mL syringes. This is a firm fixed price, competitively awarded contract with an ultimate completion date of June 17, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting open competition among qualified vendors. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for VAXNEUVANCE 0.5 ML syringes valued at $5,552.15 on May 28, 2025, with an ultimate completion date of May 29, 2025. This competitive, firm fixed-price delivery order represents a non-set-aside award for pneumococcal vaccine supply to support federal medical procurement needs. The contract's place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Vaxneuvance 0.5 mL syringes valued at $1,370.34 on August 4, 2025, with completion scheduled for August 5, 2025. This firm fixed-price contract represents a non-competitive set-aside and will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,370.39 to AmerisourceBergen Drug Corp for the supply of Vaxneuvance 0.5 mL syringes on September 16, 2025, with an ultimate completion date of September 17, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation. The award represents a single delivery transaction executed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $12,202.12 to AmerisourceBergen Drug Corp for the supply of Vaxneuvance 0.5 mL syringes on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Vaxneuvance is a pneumococcal vaccine product, reflecting the ongoing federal...